Varicella Live Vaccine Market

Varicella Live Vaccine Market | Innovative products facilitates strategic business planning

PORTLAND, OREGON, UNITED STATE, August 30, 2022 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, "Varicella Live Vaccine Market by Product, Application, and Provider: Global Opportunity Analysis and Industry Forecast, 2018-2026," the global varicella live vaccine market was valued at $2.71 billion in 2018, and is expected to reach $4.22 billion by 2026, registering a CAGR of 5.7% from 2019 to 2026.

Viral infections can be prevented by immunization and therefore, immunization is crucial. Varicella zoster is a virus that causes diseases such as chicken pox and herpes zoster. However, these infectious diseases can be prevented by the use of varicella live vaccines. Varicella live vaccines are administered to both children and adults in a pattern of two doses to ensure complete immunization. These vaccines contain a weakened form of varicella zoster virus that is effective in creating immunity against the same virus. There are two different types of varicella live vaccines such as monovalent and combination varicella vaccines.

Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/3969

Key Findings of The Varicella Live Vaccine Market:

Monovalent varicella vaccine occupied two-thirds share of the global varicella live vaccine market in 2018
The herpes zoster segment is anticipated to grow with the highest CAGR throughout the forecast period
The private segment accounted for two-third share of the market in 2018
Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA
Based on product, the monovalent varicella vaccine segment acquired the major share of the varicella live vaccine market and is expected to experience rapid growth during the forecast period as these vaccines exhibit lesser chances of inducing febrile seizures in children as compared to combination vaccines. Moreover, easy availability and presence of large number of products is another reason that boosts the growth of the monovalent varicella vaccine market.

Based on application, chicken pox immunization acquired the largest share of the varicella live vaccine market owing to vaccination employed with an initial aim of building immunity against chicken pox. Herpes zoster segment is expected to grow at the fastest rate during the forecast period owing to surge in geriatric population worldwide and rise in awareness about the use of varicella live vaccines for herpes zoster.

 Key Market Segments

BY PRODUCT
Monovalent Varicella Vaccine
Combination Varicella Vaccine
BY APPLICATION
Chickenpox Immunization
Herpes Zoster Immunization
Mumps, measles, rubella & varicella (MMRV) Immunization
BY PROVIDER
Public
Private

Key Market Players

BIO-MED PVT. LIMITED
CHANGCHUN BCHT BIOTECHNOLOGY CO. LTD
EMCURE PHARMACEUTICALS LIMITED (ZUVENTUS HEALTHCARE LTD.)
GLAXOSMITHKLINE PLC
GREEN CROSS HOLDINGS (GC PHARMA)
MERCK & CO. INC
MITSUBISHI CHEMICAL HOLDINGS CORPORATION (MITSUBISHI TANABE PHARMA CORPORATION)
NOVO MEDI SCIENCES PVT. LTD
SANOFI
TAKEDA PHARMACEUTICAL COMPANY LIMITED

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/3969

The global varicella live vaccine market is segmented based on product, application, and provider. On the basis of product, the market is bifurcated into monovalent varicella vaccine and combination varicella vaccine. By application, it is divided into chicken pox immunization, herpes zoster immunization and measles, mumps, rubella and varicella (MMRV) immunization.
We also Offers Regional and Country Reports-

Japan Varicella Live Vaccine Market
South Korea Varicella Live Vaccine Market
Singapore Varicella Live Vaccine Market
China Varicella Live Vaccine Market
Indonesia Varicella Live Vaccine Market
Australia Varicella Live Vaccine Market
Taiwan Varicella Live Vaccine Market

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Dental Consumables Market

Sports Medicine Market

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.